Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25962 | 267 | 43.4 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
258 | 3 | STROKE//INTRACEREBRAL HEMORRHAGE//CEREBRAL ISCHEMIA | 44849 |
2409 | 2 | BLOOD BRAIN BARRIER//CEREBROLYSIN//TYR MIF 1 | 4189 |
25962 | 1 | CEREBROLYSIN//CEREBROLYSIN R//QEEG SLOWING | 267 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CEREBROLYSIN | authKW | 8287220 | 37% | 72% | 100 |
2 | CEREBROLYSIN R | authKW | 571822 | 2% | 100% | 5 |
3 | QEEG SLOWING | authKW | 343093 | 1% | 100% | 3 |
4 | DEV BIOL HISTOL | address | 228729 | 1% | 100% | 2 |
5 | FPF1070 | authKW | 228729 | 1% | 100% | 2 |
6 | BISBENZIMIDE HOECHST 33258 | authKW | 114364 | 0% | 100% | 1 |
7 | BRAIN CYTOTOXIC EDEMA | authKW | 114364 | 0% | 100% | 1 |
8 | BRAIN MOL GENET | address | 114364 | 0% | 100% | 1 |
9 | BRAIN PEPTIDES CEREBROLYSIN | authKW | 114364 | 0% | 100% | 1 |
10 | CALCIUM DEPENDENT NEUTRAL PROTEASES | authKW | 114364 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 2285 | 40% | 0% | 108 |
2 | Psychiatry | 1243 | 25% | 0% | 67 |
3 | Neurosciences | 1111 | 38% | 0% | 102 |
4 | Pathology | 566 | 13% | 0% | 36 |
5 | Pharmacology & Pharmacy | 98 | 13% | 0% | 36 |
6 | Geriatrics & Gerontology | 51 | 3% | 0% | 7 |
7 | Medicine, General & Internal | 43 | 7% | 0% | 20 |
8 | Peripheral Vascular Diseases | 28 | 4% | 0% | 10 |
9 | Behavioral Sciences | 10 | 2% | 0% | 5 |
10 | Cell Biology | 10 | 5% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DEV BIOL HISTOL | 228729 | 1% | 100% | 2 |
2 | BRAIN MOL GENET | 114364 | 0% | 100% | 1 |
3 | DIS MED UNIT | 114364 | 0% | 100% | 1 |
4 | FAMILY MED NEUROL | 114364 | 0% | 100% | 1 |
5 | HEALTH IDIPAZNEUROSCI | 114364 | 0% | 100% | 1 |
6 | HISTOPHARMACOL | 114364 | 0% | 100% | 1 |
7 | HOSP SALVADORSERV NEUROLUNIDAD NEUROL COGNITIVA | 114364 | 0% | 100% | 1 |
8 | HVS IMAGING HEART VASC STROKE | 114364 | 0% | 100% | 1 |
9 | INTERNAL TRADIT CHINESE MED | 114364 | 0% | 100% | 1 |
10 | JILIN NEUROL | 114364 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 105348 | 10% | 3% | 27 |
2 | ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 46183 | 11% | 1% | 29 |
3 | ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 24796 | 10% | 1% | 27 |
4 | JOURNAL OF NEURAL TRANSMISSION | 6302 | 6% | 0% | 15 |
5 | PHYSIOLOGY INTERNATIONAL | 6017 | 0% | 5% | 1 |
6 | DRUGS OF TODAY | 1783 | 2% | 0% | 5 |
7 | INTERNATIONAL JOURNAL OF STROKE | 1748 | 1% | 0% | 4 |
8 | NEUROCHEMICAL JOURNAL | 1004 | 1% | 0% | 2 |
9 | COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 938 | 3% | 0% | 9 |
10 | HISTOCHEMICAL JOURNAL | 897 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CEREBROLYSIN | 8287220 | 37% | 72% | 100 | Search CEREBROLYSIN | Search CEREBROLYSIN |
2 | CEREBROLYSIN R | 571822 | 2% | 100% | 5 | Search CEREBROLYSIN+R | Search CEREBROLYSIN+R |
3 | QEEG SLOWING | 343093 | 1% | 100% | 3 | Search QEEG+SLOWING | Search QEEG+SLOWING |
4 | FPF1070 | 228729 | 1% | 100% | 2 | Search FPF1070 | Search FPF1070 |
5 | BISBENZIMIDE HOECHST 33258 | 114364 | 0% | 100% | 1 | Search BISBENZIMIDE+HOECHST+33258 | Search BISBENZIMIDE+HOECHST+33258 |
6 | BRAIN CYTOTOXIC EDEMA | 114364 | 0% | 100% | 1 | Search BRAIN+CYTOTOXIC+EDEMA | Search BRAIN+CYTOTOXIC+EDEMA |
7 | BRAIN PEPTIDES CEREBROLYSIN | 114364 | 0% | 100% | 1 | Search BRAIN+PEPTIDES+CEREBROLYSIN | Search BRAIN+PEPTIDES+CEREBROLYSIN |
8 | CALCIUM DEPENDENT NEUTRAL PROTEASES | 114364 | 0% | 100% | 1 | Search CALCIUM+DEPENDENT+NEUTRAL+PROTEASES | Search CALCIUM+DEPENDENT+NEUTRAL+PROTEASES |
9 | CEREBRAL ISCHEMIA CEREBRAL BLOOD FLOW | 114364 | 0% | 100% | 1 | Search CEREBRAL+ISCHEMIA+CEREBRAL+BLOOD+FLOW | Search CEREBRAL+ISCHEMIA+CEREBRAL+BLOOD+FLOW |
10 | CEREBRAL VOLUME LOSS | 114364 | 0% | 100% | 1 | Search CEREBRAL+VOLUME+LOSS | Search CEREBRAL+VOLUME+LOSS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ALVAREZ, XA , FUENTES, P , (2011) CEREBROLYSIN IN ALZHEIMER'S DISEASE.DRUGS OF TODAY. VOL. 47. ISSUE 7. P. 487 -513 | 71 | 48% | 11 |
2 | MASLIAH, E , DIEZ-TEJEDOR, E , (2012) THE PHARMACOLOGY OF NEUROTROPHIC TREATMENT WITH CEREBROLYSIN: BRAIN PROTECTION AND REPAIR TO COUNTERACT PATHOLOGIES OF ACUTE AND CHRONIC NEUROLOGICAL DISORDERS.DRUGS OF TODAY. VOL. 48. ISSUE . P. 3-24 | 41 | 69% | 26 |
3 | PLOSKER, GL , GAUTHIER, S , (2009) CEREBROLYSIN A REVIEW OF ITS USE IN DEMENTIA.DRUGS & AGING. VOL. 26. ISSUE 11. P. 893-915 | 41 | 67% | 24 |
4 | GOMAZKOV, OA , AFANASIEV, VV , RUMYANTSEVA, SA , STUPIN, VA , SILINA, EV , SOKHOVA, OA , (2011) CURRENT CONCEPTIONS OF NEUROCYTOPROTECTIVE THERAPY.ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. VOL. 111. ISSUE 12. P. 58-63 | 21 | 88% | 1 |
5 | FIGUEROA, J , ALVAREZ, A , BUCUR, N , PALADE, C , COSTEA, D , COSTEA, C , MOHAN, D , PRUNA, V , LAPADAT, M , CHIPARUS, C , ET AL (2015) A RETROSPECTIVE, MULTI-CENTER COHORT STUDY EVALUATING THE SEVERITY-RELATED EFFECTS OF CEREBROLYSIN TREATMENT ON CLINICAL OUTCOMES IN TRAUMATIC BRAIN INJURY.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 14. ISSUE 5. P. 587 -599 | 20 | 77% | 2 |
6 | THOME, J , DOPPLER, E , (2012) SAFETY PROFILE OF CEREBROLYSIN: CLINICAL EXPERIENCE FROM DEMENTIA AND STROKE TRIALS.DRUGS OF TODAY. VOL. 48. ISSUE . P. 63 -69 | 18 | 90% | 4 |
7 | ZIGANSHINA, LE , ABAKUMOVA, T , VERNAY, L , (2016) CEREBROLYSIN FOR ACUTE ISCHAEMIC STROKE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 27 | 47% | 0 |
8 | ROCKENSTEIN, E , UBHI, K , PHAM, E , MICHAEL, S , DOPPLER, E , NOVAK, P , INGLIS, C , MANTE, M , ADAME, A , ALVAREZ, XA , ET AL (2011) BENEFICIAL EFFECTS OF A NEUROTROPHIC PEPTIDERGIC MIXTURE PERSIST FOR A PROLONGED PERIOD FOLLOWING TREATMENT INTERRUPTION IN A TRANSGENIC MODEL OF ALZHEIMER'S DISEASE.JOURNAL OF NEUROSCIENCE RESEARCH. VOL. 89. ISSUE 11. P. 1812 -1821 | 28 | 47% | 9 |
9 | HAMED, SA , (2011) CEREBROLYSIN AS A NERVE GROWTH FACTOR FOR TREATMENT OF ACQUIRED PERIPHERAL NERVOUS SYSTEM DISEASES.NEURAL REGENERATION RESEARCH. VOL. 6. ISSUE 18. P. 1415 -1420 | 17 | 65% | 2 |
10 | AMIRI-NIKPOUR, MR , NAZARBAGHI, S , AHMADI-SALMASI, B , MOKARI, T , TAHAMTAN, U , REZAEI, Y , (2014) CEREBROLYSIN EFFECTS ON NEUROLOGICAL OUTCOMES AND CEREBRAL BLOOD FLOW IN ACUTE ISCHEMIC STROKE.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 10. ISSUE . P. 2299 -2306 | 16 | 62% | 6 |
Classes with closest relation at Level 1 |